Skip to content
GenoLensGenoLens

CHRNA1

Chr 2q31.1

cholinergic receptor nicotinic alpha 1 subunit

MANE:
ENST00000348749.9

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Arthrogryposis

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • Congenital myaesthenic syndrome

    BOTH monoallelic and biallelic, autosomal or pseudoautosomal
  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal anomalies

    BIALLELIC, autosomal or pseudoautosomal
  • Fetal hydrops

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • Congenital myasthenic syndromes

    0.82
  • Postsynaptic congenital myasthenic syndromes

    0.79
  • lethal multiple pterygium syndrome

    0.78
  • Muscle spasm

    0.53
  • muscle cramp

    0.53
  • postsynaptic congenital myasthenic syndrome

    0.38
  • congenital myasthenic syndrome, dominant/recessive

    0.37
  • Seizure

    0.36
  • congenital myasthenic syndrome

    0.35
  • congenital myopathy

    0.34

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Acetylcholine receptor subunit alpha

Upon acetylcholine binding, the AChR responds by an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.